Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT00038103
Eligibility Criteria:
Inclusion Criteria:
* Postmenopausal female patient with histologically or cytologically confirmed breast cancer having progressed on Tamoxifen.
* Advanced disease: patients with advanced breast carcinoma with disease progression who had progressed/relapsed following \> 8 weeks of treatment with Tamoxifen for advanced disease; or progressed during adjuvant Tamoxifen for at least 6 or 12 months depending on receptor status; or progressed within 12 months from completion of adjuvant treatment with Tamoxifen.
* at least one measurable lesion
Exclusion Criteria:
* More than one previous chemotherapy and/or more than one hormonotherapy for advanced disease.
* Previous hormonotherapy for advanced disease other than Tamoxifen.
* Myocardial infarction within previous 6 mo
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00038103
Study Brief:
Protocol Section:
NCT00038103